Nantong drugmaker trading as Novast, developing extended-release and hormonal prescription drugs, largely sold in the US.
Nantong Lianya Pharmaceutical Co., Ltd., trading as Novast, was established in 2005 in Nantong, China, by Dr. Guohua Zhang and Mr. Prasadraju Pinnamaraju. The company develops and manufactures prescription drugs, including extended-release and ultra-low-dose hormonal products, and sells mainly into the US market, where its first oral contraceptive, Philith, launched in 2012. It has filed more than 50 ANDAs with the US FDA and has around 40 approvals. In January 2021 it closed venture funding from HighLight Capital and Shiyu Capital.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in